These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7798505)

  • 1. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
    White HD; French JK; Hamer AW; Brown MA; Williams BF; Ormiston JA; Cross DB
    J Am Coll Cardiol; 1995 Jan; 25(1):218-23. PubMed ID: 7798505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity.
    French JK; Ellis CJ; Webber BJ; Williams BF; Amos DJ; Ramanathan K; Whitlock RM; White HD
    Am J Cardiol; 1998 Mar; 81(6):665-71. PubMed ID: 9527071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
    D'Urbano M; Cafiero F; Cammelli F; Spreafico GL; Romano S
    G Ital Cardiol; 1994 Jan; 24(1):11-20. PubMed ID: 8200491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.
    Veen G; Meyer A; Verheugt FW; Werter CJ; de Swart H; Lie KI; van der Pol JM; Michels HR; van Eenige MJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1755-62. PubMed ID: 8245325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of the double antiplatelet therapy on patency of the occluded artery after acute myocardial infarction with ST-segment elevation].
    Radojković DD; Perisić Z; Tomasević M; Pavlović M; Apostolović S; Janković R; Damjanović M; Martinović SS; Bozinović N; Milenković D
    Vojnosanit Pregl; 2007 Feb; 64(2):117-21. PubMed ID: 17348463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
    Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
    Ohman EM; Califf RM; Topol EJ; Candela R; Abbottsmith C; Ellis S; Sigmon KN; Kereiakes D; George B; Stack R
    Circulation; 1990 Sep; 82(3):781-91. PubMed ID: 2394002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS).
    Relik-van Wely L; Visser RF; van der Pol JM; Bartholomeus I; Couvée JE; Drost H; Vet AJ; Klomps HC; van Ekelen WA; van den Berg F
    Am J Cardiol; 1991 Aug; 68(4):296-300. PubMed ID: 1858670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
    J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome.
    Grines CL; Topol EJ; Bates ER; Juni JE; Walton JA; O'Neill WW
    Am Heart J; 1988 Jan; 115(1 Pt 1):1-7. PubMed ID: 2962478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction.
    Alhaddad IA; Tkaczevski L; Siddiqui F; Mir R; Brown EJ
    Circulation; 1995 Jun; 91(11):2819-23. PubMed ID: 7758189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction.
    Norris RM; White HD; Cross DB; Woo KS; Maslowski AH; Caruana MP; Hart HH; Williams B
    Br Heart J; 1993 Jun; 69(6):492-5. PubMed ID: 8343314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study.
    Williams MJ; Morison IM; Parker JH; Stewart RA
    J Am Coll Cardiol; 1997 Aug; 30(2):364-9. PubMed ID: 9247506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD; Keltai M; Walsh MJ
    Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
    Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.